NCT03699956 — Carcinoma, Small Cell Lung trial site landscape

Public-registry site landscape for NCT03699956, a Carcinoma, Small Cell Lung study sponsored by EpicentRx, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT03699956 (registry record)
Sponsor	EpicentRx, Inc.
Condition(s)	Carcinoma, Small Cell Lung
Phase	PHASE3
Listed sites	18
Site countries	United States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT03699956 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.